Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Shares, No Par Value
-
Shares outstanding
-
374,002,024
-
Total 13F shares
-
223,667,067
-
Share change
-
-17,476,005
-
Total reported value
-
$4,082,900,330
-
Put/Call ratio
-
117%
-
Price per share
-
$18.29
-
Number of holders
-
283
-
Value change
-
-$258,095,352
-
Number of buys
-
150
-
Number of sells
-
128
Institutional Holders of Bausch Health Companies Inc. - Common Shares, No Par Value (BHC) as of Q2 2020
As of 30 Jun 2020,
Bausch Health Companies Inc. - Common Shares, No Par Value (BHC) was held by
283 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
223,667,067 shares.
The largest 10 holders included
PAULSON & CO. INC., FIL Ltd, ValueAct Holdings, L.P., GLENVIEW CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, GOLDENTREE ASSET MANAGEMENT LP, and Connor, Clark & Lunn Investment Management Ltd..
This page lists
286
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.